(Clindamycin 600 mg/ml Injection)

PATHOCLIN Injection contains Clindamycin which is similar to and a derivative of lincomycin. It binds primarily to the 23s RNA subunit. Clindamycin may be bacteriostatic or bactericidal depending on the organism and drug concentration.

Clindamycin is a semisynthetic lincosamide antibiotic.

It is an antibacterial.

PATHOCLIN Injection can be used in the treatment of the following conditions:

  • Skin and soft tissue infections
  • Respiratory tract infections
  • Gynecological infections
  • Intra-abdominal infections
  • Septicemia
  • Bone and joint infections
  • Treatment of toxoplasmosis, diabetic foot ulcer, dental care and surgical procedure.

In serious infections due to aerobic gram-positive cocci and anaerobes, one PATHOCLIN Injection daily in 2-4 equal doses.
In severe infections due to Bacteroides fragilis, streptococcus sp., one PATHOCLIN Injection in 6-8 hours for 6 weeks.

Clindamycin inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits.

Related Products